Recombinant Tick-Borne Encephalitis Virus NS1 Protein, His-tagged
Specification
Related Products
| Cat#: |
TIC-588 |
| Product Name: |
Recombinant Tick-Borne Encephalitis Virus NS1 Protein, His-tagged |
| Description: |
Tick-Borne Encephalitis Virus NS1 protein is produced entirely from human cell lines using state-of-the-art expression techniques, the same approach which NAC used to develop its well-received Dengue Virus NS1 serotypes and West Nile Virus NS1 protein. |
| Gene: |
NS1 |
| Species: |
TBEV |
| Source: |
HEK293 |
| Synonyms: |
Tick-Borne Encephalitis Virus NS1 |
| Formulation: |
DPBS pH 7.4，0.2μm filter sterilised. |
| Concentration: |
0.524 mg/mL |
| Stability: |
At +4 centigrade: 1 week.
At -80 centigrade: 1 year. |
| Purity: |
>90% by SDS-PAGE |
| Storage: |
Short Term Storage: +2 centigrade to +8 centigrade
Long Term Storage: -20 centigrade to -80 centigrade |
| Notes: |
This product is intended for research and manufacturing uses only. It is not a diagnostic device. The user assumes all responsibility for care, custody and control of the material, including its disposal, in accordance with all regulations. |
| Tags: |
C-terminal His |
| Freezing: |
Can be frozen, but avoid multiple freeze/thaw cycles. |
| Sequence Strain: |
Neudoerfl |
| Background: |
The Tick-borne encephalitis virus (TBEV) is a Flavivirus which is transmitted to humans through a bite from an infected tick. Tick-borne encephalitis (TBE) is endemic in Europe and Asia with an average of 8,500 cases per year in Europe (https://wwwnc.cdc.gov/travel/page/yellowbook-home-2014/). TBE infected patients typically present with influenza-like symptoms and the disease is neuroinvasive often manifesting as meningitis, encephalitis or meningoencephalitis. Long-lasting or permanent neuropsychiatric sequelae are reported in 10 to 20% of patients. |
For research or industrial raw materials, not for personal medical use!
